Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;93(1):93-103.
doi: 10.1002/cyto.a.23165. Epub 2017 Jul 5.

The metabolic syndrome alters the miRNA signature of porcine adipose tissue-derived mesenchymal stem cells

Yu Meng  1   2 , Alfonso Eirin  1 , Xiang-Yang Zhu  1 , Hui Tang  1 , Pritha Chanana  3 , Amir Lerman  4 , Andre J Van Wijnen  5 , Lilach O Lerman  1   4
Affiliations

The metabolic syndrome alters the miRNA signature of porcine adipose tissue-derived mesenchymal stem cells

Yu Meng et al. Cytometry A. 2018 Jan.

Abstract

Autologous transplantation of mesenchymal stem cells (MSCs) is a viable option for the treatment of several diseases. Evidence indicates that MSCs release extracellular vesicles (EVs) and that EVs shuttle miRNAs to damaged parenchymal cells to activate an endogenous repair program. We hypothesize that comorbidities may interfere with the packaging of cargo in MSC-derived EVs. Therefore, we examined whether metabolic syndrome (MetS) modulates the miRNA content packed within MSC-derived EVs. MSCs were collected from swine abdominal adipose tissue after 16 weeks of lean or obese diet (n = 7 each). Next-generation RNA sequencing of miRNAs (miRNA-seq) was performed to identify miRNAs enriched in MSC-derived EVs and their predicted target genes. Functional pathway analysis of the top 50 target genes of the top 4 miRNAs enriched in each group was performed using gene ontology analysis. Lean- and MetS-EVs were enriched in, respectively, 14 and 8 distinct miRNAs. Target genes of miRNAs enriched in MetS-EVs were implicated in the development of MetS and its complications, including diabetes-related pathways, validated transcriptional targets of AP1 family members Fra1 and Fra2, Class A/1 (Rhodopsin-like receptors), and Peptide ligand-binding receptors. In contrast, miRNAs enriched in Lean EVs target primarily EphrinA-EPHA and the Rho family of GTPases. MetS alters the miRNA content of EVs derived from porcine adipose tissue MSCs. These alterations could impair the efficacy and limit the therapeutic use of autologous MSCs in subjects with MetS. Our findings may assist in developing adequate regenerative strategies to preserve the reparative potency of MSCs in individuals with MetS. © 2017 International Society for Advancement of Cytometry.

Keywords: extracellular vesicles; mesenchymal stem cells; metabolic syndrome; microRNA.

PubMed Disclaimer

Conflict of interest statement

Conflict of interests

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1. Overview of micro-RNA (miRNA) sequencing and functional analysis
High throughput miRNA sequencing analysis was performed in both swine adipose tissue-derived mesenchymal stem cells (MSCs) and their daughter extracellular vesicles (EVs) (n=7 each). Differentially expression analysis was performed to identify miRNAs enriched in EVs. miRNA predicted targets of top 4 miRNAs enriched in Lean- and MetS- EVs (highest fold change) were identified using TargetScan. Functional pathway analysis of top 50 target genes of top 4 miRNAs enriched in Lean- and MetS- EVs (total 200 miRNAs each) was performed using FunRich.
Figure 2
Figure 2. Characterization of MSC-derived EVs
A: Transmission electron microscopy of culture MSCs releasing EVs. B: Negative staining of MSC culture supernatants showing EV clusters (arrows) with the classic “cup-like” morphology. C: Characterization of Lean- and MetS- EVs by protein expression of common EV (CD9 and CD29) and MSC (CD105 and CD73) markers.
Figure 3
Figure 3. miRNAs enriched in Lean- and MetS- EVs
A: Of all annotated miRNAs (n=326), only 14 (miR-205, miR-486, miR-194a, miR-504, miR-342, miR-183, miR-192, miR-92a, miR-28-3p, miR-30d, miR-186, miR-320, miR-140-3p, miR-378) and 8 (miR-146a-3p, miR-30c-1-3p, miR-7, miR-148a-5p, miR-374a-3p, miR-23a, miR-132, miR-129b) distinct miRNAs were selectively enriched in Lean- and MetS- EVs, respectively. B: Total reads and fold change (EVs/MSCs) of top 4 (highest fold change) miRNAs enriched in Lean-EVs (top) and MetS-EVs (bottom).
Figure 4
Figure 4. Target genes of miRNAs enriched in Lean- and MetS- EVs
Quantitative polymerase chain reaction (qPCR) of candidate miRNAs followed the same patterns as the miRNAseq findings. miR-205, miR-486, and miR-194a were higher in Lean-EVs compared to their parent MSCs, whereas expression of miR-146a and miR-30c-1-3p were higher in MetS-EVs versus MetS-MSCs. B: Venn diagram showing distribution of miRNA target genes of miRNAs enriched in Lean- and MetS- EVs. A total of 194 and 198 target genes were identified for miRNAs enriched in Lean- and MetS- EVs, but only 7 EV-enriched miRNA targets overlapped between these 2 groups. A total of 194 and 198 target genes were identified for miRNAs enriched in Lean- and MetS- EVs, but only 7 EV-enriched miRNA targets overlapped between these 2 groups.
Figure 5
Figure 5. Functional pathway analysis of target genes of miRNAs enriched in Lean- and MetS- EVs
Classification of gene targets of miRNAs enriched in Lean- and MetS- EVs by cellular component, molecular function, biological process, and biological pathway.
See this image and copyright information in PMC

Comment in

References

    1. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315–7. - PubMed
    1. Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med. 2011;6(4):481–92. - PubMed
    1. Yeo RW, Lai RC, Zhang B, Tan SS, Yin Y, Teh BJ, Lim SK. Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery. Adv Drug Deliv Rev. 2013;65(3):336–41. - PubMed
    1. Eirin A, Riester SM, Zhu XY, Tang H, Evans JM, O’Brien D, van Wijnen AJ, Lerman LO. MicroRNA and mRNA cargo of extracellular vesicles from porcine adipose tissue-derived mesenchymal stem cells. Gene. 2014;551(1):55–64. - PMC - PubMed
    1. Eirin A, Zhu XY, Puranik AS, Woollard JR, Tang H, Dasari S, Lerman A, van Wijnen AJ, Lerman LO. Integrated transcriptomic and proteomic analysis of the molecular cargo of extracellular vesicles derived from porcine adipose tissue-derived mesenchymal stem cells. PLoS One. 2017;12(3):e0174303. - PMC - PubMed

MeSH terms

LinkOut - more resources